the Novartis Vaccines Institute for Global Health (NVGH), part of the Novartis Institutes for BioMedical Research, has developed a typhoid vaccine with funding by the Fondazione Monte dei Paschi ...

Jay Bradner, president of the Novartis Institutes for Biomedical Research (NIBR), is retiring from the position after seven years in the role, and will be replaced by Merck & Co R&D executive ...

The pharma will pay $800 million for the biotech, which was launched nearly two decades ago by Alnylam and Ionis to advance ...

Sato, Vicki, Christoph Jaeker, and Pooja Mehta Solanki. "China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise." Harvard Business School ...

Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...

(Reuters) -Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental drug to treat a life-threatening kidney disease. Under the ...

Novartis, a Swiss pharmaceutical company ... According to the company, one of its biomedical research innovation hubs will be based in San Diego, and it will look to expand three radiogland ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Dr. Roubenoff is Head of Global Translational Medicine for Musculoskeletal Diseases at Novartis Institutes for Biomedical Research. He has done pioneering work on the interactions of nutrition, ...

SAN DIEGO (FOX 5/KUSI) — Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San Diego as part of a wider effort to expand its ...